基本情報
- CAS
14176-50-2- 標準SMILES
CCNC1(c2cccs2)CCCCC1=O.Cl- InChIKey
ZUYKJZQOPXDNOK-UHFFFAOYSA-N- 分子式
- C12H18ClNOS
- 平均分子量
- 259.8 g/mol
- 単同位体質量
- 259.0797631
概要
See also: Tiletamine (has active moiety); Tiletamine Hydrochloride; Zolazepam Hydrochloride (component of).
名称と識別子
- 優先名称
- Tiletamine Hydrochloride
- IUPAC
- 2-(ethylamino)-2-thiophen-2-ylcyclohexan-1-one;hydrochloride
名称と別名
TILETAMINE HYDROCHLORIDE14176-50-2Tiletamine HClCL 399CI-634CN-54521-2DTXSID604553999TAQ2QWJINSC-167740Cyclohexanone, 2-(ethylamino)-2-(2-thienyl)-, hydrochloride2-(Ethylamino)-2-(2-thienyl)cyclohexanone hydrochlorideCI 634
名称をさらに表示
CL-399DTXCID4025539NSC167740RefChem:58252Hydrochloride, TiletamineCI634Tiletamin hydrochlorideTiletamine (hydrochloride)
データベース識別子
- CAS
14176-50-2- PubChem CID
- 26534
- DTXSID
DTXSID6045539- ChEMBL
CHEMBL2105342- UNII
- 99TAQ2QWJI
- EC Number
- 604-248-6
物性
構造計算による物性
- 極性表面積
- 57.3 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 3
- 回転可能結合数
- 3
- 重原子数
- 16
- 形式電荷
- 0
- 複雑度
- 244
実験および物理化学的性質
Animal DrugsFDA approved animal drugs -> Active ingredient
安全と法規制
安全情報は参考情報です。供給元の安全データシート（SDS）、適用法令、専門家による評価に代わるものではありません。
GHS分類
GHS Classification
Warning
H336 (100%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposure; Narcotic effects]
P261, P271, P304+P340, P319, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
危険有害性情報
Regulatory InformationTiletamine hydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesSTOT SE 3 (100%)
化学と産業
薬理情報
MeSH Pharmacological Classification
Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed)
Drugs used to prevent SEIZURES or reduce their severity.
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…